A meta-analysis of anti-PD-1 and anti_PD-L1 treatment of NSCLC patients supplemented or not with chemotherapy showed greater effect of anti-PD-1 alone in men, whereas women benefitted better from anti-PD-1 and anti-PD-L1 together with chemotherapy (112). This evidence concerns the gene CD274 and non-small cell lung carcinoma.